N-Zyme Biomedical
Business Services · Wisconsin, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1225 Discovery Pkwy, Milwaukee, Wisconsi...Website
www.nzymebio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About N-Zyme Biomedical
N-Zyme Biomedical is focused on developing safe and effective treatments for laryngopharyngeal reflux (LPR), a condition affecting 10-30% of the U.S. population. The company aims to revolutionize the reflux industry by creating the world's first pepsin inhibitor, utilizing innovative drug delivery methods to enhance efficacy. Their research highlights the therapeutic potential of repurposing existing drugs, particularly HIV protease inhibitors, to address the unmet medical needs of LPR patients. N-Zyme is committed to ethical practices and collaborates with leading scientists and regulatory experts to advance their clinical programs.Explore more
N-Zyme Biomedical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is N-Zyme Biomedical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if N-Zyme Biomedical has recently received funding, and reach out quickly before it becomes old news!
N-Zyme Biomedical, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when N-Zyme Biomedical launches new products
Click to see if N-Zyme Biomedical had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if N-Zyme Biomedical is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on N-Zyme Biomedical recently announced quarterly report
Funding: Get notified immidiatlly once N-Zyme Biomedical has new funding data
Congratulate Masked Content for being promoted to Masked Content at N-Zyme Biomedical
Recommended Actions
Find VP level buyers at N-Zyme Biomedical
Find 2 more new buyers
Compare Similar Companies to N-Zyme Biomedical
Compare insights from companies similar to N-Zyme Biomedical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
N-Zyme Biomedical is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
N-Zyme Biomedical is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about N-Zyme Biomedical.
N-Zyme Biomedical financials insights
Gather financial insights about N-Zyme Biomedical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Series A
$4.6M
N-Zyme Biomedical Tech Stack
A closer look at the technologies used by N-Zyme Biomedical
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding N-Zyme Biomedical
Sign Up For FreeTo access detailed company insights
N-Zyme Biomedical is focused on developing safe and effective treatments for laryngopharyngeal reflux (LPR), a condition affecting 10-30% of the U.S. population. The company aims to revolutionize the reflux industry by creating the world's first pepsin inhibitor, utilizing innovative drug delivery methods to enhance efficacy. Their research highlig... Read More
